PharmaWeek
Thurs., July 10, 2008 |  PharmaWeek.com | Archives | Advertising | Your Account | CHI Conferences |  Subscribe |
Sales Contacts
For advertising information contact: 

Alan El Faye
VP, Advertising Sales - CA, Western US, Midwest, South Eastern US, Europe, Canada, Pacific Rim
213-300-3886 

Kay O. Christopher
Regional Sales Manager, Advertising Sales -New England, North Eastern US
860-693-2991

Tom Loughran
Regional Sales Manager, Advertising Sales -Midwest, South Eastern US, Europe
781-972-5482

Contact the Editor
PharmaWeek welcomes your feedback. Please contact Catherine Varmazis or Allison Proffitt for editorial inquiries. 

Link to Us! 
You are welcome to link to articles on our website. Contact Catherine Varmazis for details.

e-Prints & Reprints 
To post a full article from PharmaWeek or Bio-IT World on your website (not just a link), or for paper reprints, please contact:
Becky Mullaney
The YGS Group
717-399-1900 ext.110

Dear Colleague,
Welcome to this week's eNewsletter covering breaking R&D news and business insights, and featuring a Best Practice from GlaxoSmithKline and the Bio-IT World 2008 Best Practices competition.   
 
BREAKING R&D NEWS
 

FDA Makes Changes to Non-Approval Notifications
New York Times [July 9] FDA announced yesterday changes to its notification process for drugs submitted for approval. Rather than sending “approvable” or “not approvable” letters, FDA will send “complete response letters.” The goal is partly to avoid scaring investors. The changes go into effect August 11. More

Novartis Buys Majority Stake in Speedel
Bloomberg [July 10] Novartis purchased a majority of Speedel shares, 51.7% in addition to the 9.7% the pharma company previously owned. Novartis also announced that it intends to buy all remaining shares of the Swiss biopharma in a mandatory public tender offer. The total acquisition is expected to cost about $880 million. More

Eli Lilly to Buy SGX Pharmaceuticals
Forbes/AP [July 9] Indianapolis-based Eli Lilly will pay $3 per share for the San Diego-based biotech company, marking a premium of more than double SGX's closing price of $1.37 Tuesday. The companies have been collaborating since 2003 and the deal will now allow Eli Lilly to expand its biotechnology development platform along with a portfolio of potential cancer treatments. More

 
 
BUSINESS INSIGHTS 
 

CDC Reports 8000 Adverse Events from Gardasil Vaccine, Merck Stock Falls
CNN/Bloomberg [July 7] Merck experiences fall stock prices after CDC reports almost 8000 adverse reactions to the Gardasil vaccine. This comes after FDA refused to approve an expanded indication for the HPV vaccine. Analysts cut their ratings of Merck based on low expected second quarter sales for Gardasil. Stock fell almost 5% on Monday following the report. More

Pharma Cuts 800 New Jersey Jobs
CNN Money [July 8] With changes starting in August, Johnson & Johnson and Schering-Plough plan to cut approximately 800 jobs in New Jersey. Cuts come for J&J’s Centocor and Ortho Biotech units that are combining and at Schering-Plough’s Kenilworth location. More

Boehringer Ingelheim Sued for Unusual
Adverse Effect

Daily News [July 9] A former Prudential exec is suing drug-maker Boehringer Ingelheim, claiming that the company’s Parkinson’s drug, Mirapex, caused compulsive behaviors that led to a gambling addiction. The company is facing similar suits around the country. More

 

For More Recent Articles >>

 

LIFE SCIENCE JOBS

Friedrich Miescher Institute for Biomedical Research - Part of the Novartis Research Foundation
Basel, Switzerland is looking for a Head of IT Systems & Infrastructure. You will manage a cutting-edge core server and network infrastructure, comprising Linux and Solaris, as well as a robust Windows and Macintosh environment. We look forward to receiving your application: human.resources@fmi.ch. click for more information

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics, 
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit:
 LSCDD

Lilly Singapore Center for Drug Discovery (LSCDD)- Senior Bioinformatics Scientist,
Contribute to the development of novel algorithms, data analysis methods and software tools for drug discovery as part of the Integrative Computational Sciences (ICS) department at LSCDD.  Work closely with informatics and software engineering peers at ICS, and collaborate with the Discovery IT organization in Europe and USA. The successful candidate will offer hands-on insight and expertise in tailored therapeutic informatics and statistical analyses at the post-genomic era. For additional information, or to apply visit:
 LSCDD   

Lilly Singapore Center for Drug Discovery (LSCDD) - Manager, Software Engineering (Integrative Computational Sciences)
Join the Integrative Computational Sciences (ICS) department at Lilly Singapore Centre for Drug Discovery (LSCDD),as Manager Software Engineering.  Lead the development of integrated applications to process and visualize data from cutting edge technologies used by scientists at Lilly Research Labs (LRL) and the Drug Discovery Research (DDR) teams. Masters in Computer Science/Engineering or related discipline, 10+ years post graduation experience , 2 years management experience needed. For a complete job description and requirements or to apply visit: LSCDD 

Lilly Singapore Center for Drug Discovery(LSCDD) -Senior Software Engineer, 
Join a strong team of software engineers in our Integrative Computational Sciences (ICS) at LSCDD. Collaborate with, and help develop integrated applications to process and visualize data from cutting-edge technologies used by scientists at Lilly Research Labs (LRL) and the Drug Discovery Research (DDR) teams. The Software Engineering team provides computational tools and tailored software solutions that enable the global effort of Tailored Therapeutics; ‘The Right Drug, at The Right Dose for The Right Patient at The Right Time'. For additional information, or to apply visit:
 LSCDD  

Memorial Sloan-Kettering Cancer Center - Linux Systems Administrator - MSKCC Bioinformatics Core in Manhattan seeks Linux Systems Administrator. Install, configure and update monitor and troubleshoot HPC cluster, email and web servers.  Master's degree and 5 years experience with HPC, network security, Postfix, Apache, Tomcat, Grid Engine. Solaris, Email bicjobs@cbio.mskcc.org or www.mskcc.org #015429. EOE/AA 

Unilever - Mathematical Modeller (Research Scientist)
This research is leading to the requirement for integration of both biological and chemical data that may not be amenable to analysis through traditionally used techniques. The ability to work in multidisciplinary teams alongside biologists, chemists and statisticians plus enthusiasm for learning new science is critical for the role.   For a complete job description and to apply, please visit:
 https://unilever.recruitmax.com/ 

More Life Science Jobs ~ Add a Job Listing

 

FEATURED EVENTS

Multiplexed Genomics Tools: Targeting the Missing Links
Between Health and Disease - September 21-23, 2008 • Providence, RI

Next-Generation Sequencing Data Analysis -September 22-23, 2008 • Providence, RI

Barnett Educational Services, 2008 Schedule

To have your event featured here, contact Lynn Cloonan for more information.

 Email to a Friend 

PHARMA BEST PRACTICES

GSK Moving Upstream with Signal Detection
By Deborah Borfitz

July 14, 2008 | Cross-functional Safety Review Teams (SRTs) at GlaxoSmithKline are moving into full production with a clinical trials signal detection (CTSD) tool that is useful for evaluating data emerging from both ongoing and completed studies. In doing so, it is raising the standard for safety review while potentially reducing the cost of statistical programming support for its current study portfolio.
Read More

EXCLUSIVE WEBCAST

NEW! Life Science Webcasts from Bio-IT World and Cambridge Healthtech Media Group

Life Science Webcasts

Bio-IT World Expo
Video Highlights

Personalized Genetics: Advancements and Driving Change
Linda Avey, co-founder of 23andMe, delivers her keynote at the 2008 Bio-IT World Conference & Expo in Boston, April 30, 2008.
View the Webcast Now.

The Future of Personal Genomics
A distinguished panel of personal genomics experts discuss the future of personal genomics at the 2008 Bio-IT World Conference & Expo in Boston, April 30, 2008.  They include Dietrich Stephan (co-founder, Navigenics); George Church (Harvard Medical School);
Jeff Drazen (editor-in-chief, New England Journal Medicine); Fred Ledley (Bentley College); John Halamka (CIO, Harvard Medical School); and Linda Avey (23andMe). Bio-IT World Editor-in-Chief Kevin Davies moderates the discussion.
View the Webcast Now

Insight Pharma Reports

Systems Biology: A Disruptive Technology

This report focuses on current and future applications of Systems Biology in drug discovery and describes radically new concepts emerging from basic Systems Biology research. More Information

Custom Market Research Services
Our experienced research team will work with you to fully understand your needs in order to create and conduct a custom market research program that meets your objectives.
Learn More

Featured Content

Will Healthcare IT Trends Standardize?
A new wave of activities are driving transformation within the healthcare market. One solution is found in a guide to PDF Healthcare Best Practices. This “Best Practices Guide” describes Portable Document Format (PDF) attributes and use to facilitate the capture, exchange, preservation and protection of healthcare information. This webinar will focus on trends in today’s healthcare market, the challenges in overcoming these issues, and finally how to use best practices to improve patient care, enhance productivity and eliminate paperwork. It’s hosted by Adobe and moderated by Digital Healthcare & Productivity Executive Editor, John Russell. Click here...
 
 
  

Spain’s Emerging Biotech Revolution
The biotechnology sector is growing 10 percent faster in Spain than it is in the U.S. Driven by a culture, government and private sector that are open-minded and optimistic, Spain-based companies are emerging as leaders in this dynamic field. Discover how your business can capitalize on creative solutions from Spain-based enterprises. Download Now
 
 
  
  
  
 

Waters
Automate Method SOPs for Greater Efficiency and Fewer Errors with Waters® NuGenesis® Intelligent Procedure Manager
The Waters® NuGenesis® SDMS Intelligent Procedure Manager is a workflow software package designed to guide the laboratory analyst through a routine, comprehensive method standard operating procedure (SOP) and integrate results with a chromatography data system. The Intelligent Procedure Manager addresses the predominately manual activities required to perform an analytical method or test, reducing cycle times up to 50-75% as compared to a traditional paper trail with fewer opportunities for human error.  From late-stage development to final product quality control and lot release, Intelligent Procedure Manager can be applied to any lab environment where rigorous adherence to approved test methods and SOPs must be followed, including compliance requirements for cGMP operations.Download Now

This Bio•IT World Briefing On “Next-Generation Sequencing,”underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data. Download now 

To have your white paper featured here, contact Lynn Cloonan for more information.


Cambridge
                                Healthtech InstitutePublished by Cambridge Healthtech Institute (CHI). Copyright © 2008, all rights reserved. No material may be reproduced electronically or in print without written permission from CHI, 250 First Ave., Needham, MA 02494-2814. For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA; 17601 717-399-1900 ext.110, or email: becky.mullaney@theYGSgroup.com